Back
For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".
To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".
During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center.
Preparing your E-Poster
Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.
E-Poster Submission Deadline
Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.
Please follow the instructions below to input your abstract title.
Abstract titles should be brief and reflect the content of the abstract.
Lupus nephritis (LN) affects 60% of individuals with Systemic Lupus Erythematosus (SLE) and poses a significant risk of progression to kidney failure. Racial disparities in LN prognosis may be due to genetic, environmental, and socio-economic factors that drive differential treatment response. However, data from Southeast Asia is scarce. This study aimed to assess the relationship between the race and LN remission in Singapore.
We performed a single-centre, retrospective cohort study with convenience sampling of all adults diagnosed with biopsy-confirmed LN between 2018 and 2020. Data was retrieved from electronic medical records every 6 months for three years from diagnosis. The outcome was remission (improved proteinuria <0.5 g/g and stable or improved kidney function). To account for variability across patients and repeated measures over time, we used mixed effects logistic regression to examine the association of race with remission included random intercepts for patientsand fixed effects for follow-up duration.
We included 73 adults (Chinese 77.1%, Malay 11.6%, Indian 3.3%) with median eGFR 107.0 (interquartile range [IQR]: 74.4, 122.7) ml/min1.73 m2 and urine protein-to-creatinine ratio 3.28 (IQR: 1.51, 7.47) g/g. Remission occurred in 215 of the 301 visits (71.4%): 159 of 232 visits (68.5%) for Chinese, 26 of 35 visits (74.3%) for Malays and 7 of 10 visits (70%) for Indians. There was no difference in remission for Malays (adjusted OR 1.55, 95% CI: 0.32–7.4, p=0.59) and Indians (adjusted OR 0.90, 95% CI: 0.06–12.18, p=0.94) compared to Chinese.
In this multi-racial Southeast Asian cohort, there was nosignificant difference in LN remission at 6-monthly follow-up visits for Malays and Indians, compared to Chinese.
